Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI claim is fully supported by the FDA label excerpts: the Boxed Warning states cigarette smoking increases serious cardiovascular events risk from COC use and that COCs are contraindicated in women over 35 who smoke; Contraindications (4) and Warnings/Precautions (5.1) corroborate the same threshold.
Category Scores
Accurate Statements
Cigarette smoking increases the risk of serious cardiovascular events from Minzoya (a combination oral contraceptive).
Boxed Warning: “Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use.”
Minzoya is contraindicated in women over age 35 who smoke.
Boxed Warning: “COCs are contraindicated in women who are over 35 years of age and smoke [see Contraindications (4)].” Also Contraindications (4): “Smoke, if over age 35”.
Unsupported Statements
Contradictions
Important Omissions
The claim does not explicitly mention the label’s additional modifiers (e.g., risk increases with age and number of cigarettes; “particularly” in women over 35 who smoke).
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
No unsafe or contradictory information was added; both the risk statement and the specific contraindication threshold (over 35 and smoking) are directly supported by the label excerpts.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Minor omission of label nuance (risk increases with number of cigarettes and is 'particularly' higher in women over 35 who smoke).
Suggested Improvement
Optionally include the label’s stated nuance from the Boxed Warning (age and number of cigarettes; 'particularly' in women over 35 who smoke) while keeping the core contraindication threshold.